These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2336 related articles for article (PubMed ID: 24222016)

  • 21. [New guidelines on treatment of blood cholesterol: too much of a good thing?].
    Lippi G; Mattiuzzi C
    Recenti Prog Med; 2014 Sep; 105(9):317-21. PubMed ID: 25229759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controversial step forward: A commentary on the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults.
    Ades PA
    Coron Artery Dis; 2014 Jun; 25(4):360-3. PubMed ID: 24518291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol.
    Smith SC; Grundy SM
    J Am Coll Cardiol; 2014 Aug; 64(6):601-12. PubMed ID: 25104531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2018 Cholesterol Guidelines: Key Topics in Primary Prevention.
    Clark D; Virani SS
    Curr Atheroscler Rep; 2019 Mar; 21(5):17. PubMed ID: 30877397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
    Stone NJ; Robinson JG; Lichtenstein AH; Goff DC; Lloyd-Jones DM; Smith SC; Blum C; Schwartz JS;
    Ann Intern Med; 2014 Mar; 160(5):339-43. PubMed ID: 24474185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention.
    Grundy SM; Stone NJ
    JAMA Cardiol; 2019 May; 4(5):488-489. PubMed ID: 30969322
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
    ; Lloyd-Jones DM; Morris PB; Ballantyne CM; Birtcher KK; Daly DD; DePalma SM; Minissian MB; Orringer CE; Smith SC
    J Am Coll Cardiol; 2016 Jul; 68(1):92-125. PubMed ID: 27046161
    [No Abstract]   [Full Text] [Related]  

  • 30. Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.
    Weinberger Y; Han BH
    Drugs Aging; 2015 Feb; 32(2):87-93. PubMed ID: 25586520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New points and limits of 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults].
    Ye P
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):87-8. PubMed ID: 24767156
    [No Abstract]   [Full Text] [Related]  

  • 32. Current Controversies With Recent Cholesterol Treatment Guidelines.
    Phillips E; Saseen JJ
    J Pharm Pract; 2016 Feb; 29(1):15-25. PubMed ID: 26611871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention.
    Grundy SM; Stone NJ
    JAMA Cardiol; 2019 Jun; 4(6):589-591. PubMed ID: 30994869
    [No Abstract]   [Full Text] [Related]  

  • 34. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
    Virani SS
    Tex Heart Inst J; 2016 Aug; 43(4):313-4. PubMed ID: 27547139
    [No Abstract]   [Full Text] [Related]  

  • 35. The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide.
    Gupta A; Smith DA
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):869-92. PubMed ID: 25432387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Goff DC; Lloyd-Jones DM; Bennett G; Coady S; D'Agostino RB; Gibbons R; Greenland P; Lackland DT; Levy D; O'Donnell CJ; Robinson JG; Schwartz JS; Shero ST; Smith SC; Sorlie P; Stone NJ; Wilson PW; Jordan HS; Nevo L; Wnek J; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Smith SC; Tomaselli GF;
    Circulation; 2014 Jun; 129(25 Suppl 2):S49-73. PubMed ID: 24222018
    [No Abstract]   [Full Text] [Related]  

  • 37. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    ; Drozda JP; Ferguson TB; Jneid H; Krumholz HM; Nallamothu BK; Olin JW; Ting HH; ; Heidenreich PA; Albert NM; Chan PS; Curtis LH; Ferguson TB; Fonarow GC; Ho PM; O'Brien S; Russo AM; Thomas RJ; Ting HH; Varosy PD
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):68-95. PubMed ID: 26666514
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
    Bucheit JD; Helsing H; Nadpara P; Virani SS; Dixon DL
    J Clin Lipidol; 2018; 12(2):367-374.e3. PubMed ID: 29277495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines.
    Virani SS; Akeroyd JM; Smith SC; Al-Mallah M; Maddox TM; Morris PB; Petersen LA; Ballantyne CM; Grundy SM; Stone NJ
    J Am Coll Cardiol; 2019 Aug; 74(5):712-714. PubMed ID: 31370962
    [No Abstract]   [Full Text] [Related]  

  • 40. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
    Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
    J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 117.